𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination therapy of heceptin and ad-mda7 inhibits growth of her-2/neu overexpressing breast cancer in vivo

✍ Scribed by T. S. McKenzie; Y. Lui; S. Swisher; A. Pataer; S. Chada; M. Fanale; K. Hunt


Book ID
110547752
Publisher
Springer
Year
2004
Tongue
English
Weight
210 KB
Volume
11
Category
Article
ISSN
1068-9265

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Tumor inhibitory effect of gefitinib (ZD
✍ Daisuke Takabatake; Takeo Fujita; Tadahiko Shien; Kensuke Kawasaki; Naruto Taira πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 588 KB

## Abstract Some kinds of breast cancer cell lines, similar to several types of solid tumors, express epidermal growth factor receptor (EGFR). However, gefitinib, an EGFR tyrosine kinase inhibitor, is not effective for all these cell lines. Similarly, taxane is effective for many of the cell lines,